BACKGROUND AND PURPOSE: Potentiating neurosteroids are some of the most efficacious modulators of the mammalian GABA(A) receptor. One of the crucial interactions may be between the C20 ketone group (D-ring substituent at C17) of the neurosteroid, and the N407 and Y410 residues in the M4 domain of the receptor. In this study, we examined the contribution of hydrogen bonding between 17beta-substituents on the steroid D-ring and the GABA(A) receptor to potentiation by neurosteroids. EXPERIMENTAL APPROACH: Whole-cell and single-channel recordings were made from HEK 293 cells transiently expressing wild-type and mutant alpha1beta2gamma2L GABA(A) receptors. KEY RESULTS: A steroid with a 17beta-carbonitrile group (3alpha5alpha18nor17betaCN) was a potent and efficacious potentiator of the GABA(A) receptor. Potentiation was also shown by a cyclosteroid in which C21 and the C18 methyl group of (3alpha,5alpha)-3-hydroxypregnan-20-one are connected within a six-membered ring containing a double bond as a hydrogen bond acceptor (3alpha5alphaCDNC12), a steroid containing a 17beta-ethyl group on the D-ring (3alpha5alpha17betaEt) and a steroid lacking a 17beta-substituent on the D-ring (3alpha5alpha17H). Single-channel kinetic analysis indicates that the kinetic mechanism of action is the same for the neurosteroid 3alpha5alphaP, 3alpha5alpha18nor17betaCN, 3alpha5alphaCDNC12, 3alpha5alpha17betaEt and 3alpha5alpha17H. Interestingly, 3alpha5alpha17betaEt, at up to 3 microM, was incapable of potentiating the alpha1N407A/Y410F double mutant receptor. CONCLUSIONS AND IMPLICATIONS: Hydrogen bonding between the steroid 17beta-substituent and the GABA(A) receptor is not a critical requirement for channel potentiation. The alpha1N407/Y410 residues are important for neurosteroid potentiation for reasons other than hydrogen bonding between steroid and receptor.
BACKGROUND AND PURPOSE: Potentiating neurosteroids are some of the most efficacious modulators of the mammalian GABA(A) receptor. One of the crucial interactions may be between the C20 ketone group (D-ring substituent at C17) of the neurosteroid, and the N407 and Y410 residues in the M4 domain of the receptor. In this study, we examined the contribution of hydrogen bonding between 17beta-substituents on the steroid D-ring and the GABA(A) receptor to potentiation by neurosteroids. EXPERIMENTAL APPROACH: Whole-cell and single-channel recordings were made from HEK 293 cells transiently expressing wild-type and mutant alpha1beta2gamma2L GABA(A) receptors. KEY RESULTS: A steroid with a 17beta-carbonitrile group (3alpha5alpha18nor17betaCN) was a potent and efficacious potentiator of the GABA(A) receptor. Potentiation was also shown by a cyclosteroid in which C21 and the C18 methyl group of (3alpha,5alpha)-3-hydroxypregnan-20-one are connected within a six-membered ring containing a double bond as a hydrogen bond acceptor (3alpha5alphaCDNC12), a steroid containing a 17beta-ethyl group on the D-ring (3alpha5alpha17betaEt) and a steroid lacking a 17beta-substituent on the D-ring (3alpha5alpha17H). Single-channel kinetic analysis indicates that the kinetic mechanism of action is the same for the neurosteroid 3alpha5alphaP, 3alpha5alpha18nor17betaCN, 3alpha5alphaCDNC12, 3alpha5alpha17betaEt and 3alpha5alpha17H. Interestingly, 3alpha5alpha17betaEt, at up to 3 microM, was incapable of potentiating the alpha1N407A/Y410F double mutant receptor. CONCLUSIONS AND IMPLICATIONS: Hydrogen bonding between the steroid17beta-substituent and the GABA(A) receptor is not a critical requirement for channel potentiation. The alpha1N407/Y410 residues are important for neurosteroid potentiation for reasons other than hydrogen bonding between steroid and receptor.
Authors: Gustav Akk; Hong-Jin Shu; Cunde Wang; Joe Henry Steinbach; Charles F Zorumski; Douglas F Covey; Steven Mennerick Journal: J Neurosci Date: 2005-12-14 Impact factor: 6.167
Authors: Ping Li; John Bracamontes; Bryson W Katona; Douglas F Covey; Joe Henry Steinbach; Gustav Akk Journal: Mol Pharmacol Date: 2007-03-06 Impact factor: 4.436
Authors: Zi-Wei Chen; Brad Manion; R Reid Townsend; David E Reichert; Douglas F Covey; Joe Henry Steinbach; Werner Sieghart; Karoline Fuchs; Alex S Evers Journal: Mol Pharmacol Date: 2012-05-30 Impact factor: 4.436
Authors: John Bracamontes; Megan McCollum; Caroline Esch; Ping Li; Jason Ann; Joe Henry Steinbach; Gustav Akk Journal: Mol Pharmacol Date: 2011-04-15 Impact factor: 4.436
Authors: Zi-Wei Chen; Cunde Wang; Kathiresan Krishnan; Brad D Manion; Randy Hastings; John Bracamontes; Amanda Taylor; Megan M Eaton; Charles F Zorumski; Joseph H Steinbach; Gustav Akk; Steven Mennerick; Douglas F Covey; Alex S Evers Journal: Psychopharmacology (Berl) Date: 2014-04-23 Impact factor: 4.530
Authors: Gustav Akk; Douglas F Covey; Alex S Evers; Steven Mennerick; Charles F Zorumski; Joe Henry Steinbach Journal: Curr Neuropharmacol Date: 2010-03 Impact factor: 7.363
Authors: Selwyn S Jayakar; David C Chiara; Xiaojuan Zhou; Bo Wu; Karol S Bruzik; Keith W Miller; Jonathan B Cohen Journal: J Biol Chem Date: 2020-06-15 Impact factor: 5.157
Authors: Zi-Wei Chen; John R Bracamontes; Melissa M Budelier; Allison L Germann; Daniel J Shin; Krishnan Kathiresan; Ming-Xing Qian; Brad Manion; Wayland W L Cheng; David E Reichert; Gustav Akk; Douglas F Covey; Alex S Evers Journal: PLoS Biol Date: 2019-03-07 Impact factor: 8.029